Physician profile
Carolyn C Novak
NPI 1093022394
$6,835.33
in general payments reported to CMS, 2019-2025
17 companies · $994 in 2025
The $994 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $490 · 2021: $437 · 2022: $827 · 2023: $854 · 2024: $2,363 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780 · Travel and Lodging: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.32 |
| Travel and Lodging | $1,431.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,548.30 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $1,133.62 | 2019-2025 | Precision7, Total30 |
| Bausch & Lomb Americas INC. | $596.21 | 2022-2025 | Infuse, Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $585.30 | 2019-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $353.92 | 2019-2021 | |
| Dompe US, INC. | $233.04 | 2024-2025 | Oxervate |
| Glaukos Corporation | $221.61 | 2022-2025 | Idosetr |
| Johnson & Johnson Vision Care, INC. | $203.31 | 2019-2023 | Acuvue |
| Oyster Point Pharma, INC. | $195.30 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $148.80 | 2025 | |
| Lkc Technologies, INC. | $138.15 | 2025 | |
| Amgen INC. | $124.74 | 2024 | Tepezza |
| Abbvie INC. | $124.74 | 2022 | |
| Kala Pharmaceuticals, INC. | $91.06 | 2021 | |
| Biotissue Holdings INC. | $81.90 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $30.00 | 2021 | |
| Allergan, INC. | $25.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Novak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.